191 related articles for article (PubMed ID: 31945264)
1. Crystal structure of botulinum neurotoxin subtype A3 cell binding domain in complex with GD1a co-receptor ganglioside.
Gregory KS; Liu SM; Acharya KR
FEBS Open Bio; 2020 Mar; 10(3):298-305. PubMed ID: 31945264
[TBL] [Abstract][Full Text] [Related]
2. Crystal Structures of Botulinum Neurotoxin Subtypes A4 and A5 Cell Binding Domains in Complex with Receptor Ganglioside.
Gregory KS; Mojanaga OO; Liu SM; Acharya KR
Toxins (Basel); 2022 Feb; 14(2):. PubMed ID: 35202156
[TBL] [Abstract][Full Text] [Related]
3. Structural Features of
Gregory KS; Mahadeva TB; Liu SM; Acharya KR
Toxins (Basel); 2022 May; 14(5):. PubMed ID: 35622602
[TBL] [Abstract][Full Text] [Related]
4. Glycosylated SV2 and gangliosides as dual receptors for botulinum neurotoxin serotype F.
Fu Z; Chen C; Barbieri JT; Kim JJ; Baldwin MR
Biochemistry; 2009 Jun; 48(24):5631-41. PubMed ID: 19476346
[TBL] [Abstract][Full Text] [Related]
5. Botulinum neurotoxin serotype C associates with dual ganglioside receptors to facilitate cell entry.
Karalewitz AP; Fu Z; Baldwin MR; Kim JJ; Barbieri JT
J Biol Chem; 2012 Nov; 287(48):40806-16. PubMed ID: 23027864
[TBL] [Abstract][Full Text] [Related]
6. Structure of dual receptor binding to botulinum neurotoxin B.
Berntsson RP; Peng L; Dong M; Stenmark P
Nat Commun; 2013; 4():2058. PubMed ID: 23807078
[TBL] [Abstract][Full Text] [Related]
7. The HCC-domain of botulinum neurotoxins A and B exhibits a singular ganglioside binding site displaying serotype specific carbohydrate interaction.
Rummel A; Mahrhold S; Bigalke H; Binz T
Mol Microbiol; 2004 Feb; 51(3):631-43. PubMed ID: 14731268
[TBL] [Abstract][Full Text] [Related]
8. High resolution crystal structures of Clostridium botulinum neurotoxin A3 and A4 binding domains.
Davies JR; Rees J; Liu SM; Acharya KR
J Struct Biol; 2018 May; 202(2):113-117. PubMed ID: 29288126
[TBL] [Abstract][Full Text] [Related]
9. Botulinum neurotoxin serotype D attacks neurons via two carbohydrate-binding sites in a ganglioside-dependent manner.
Strotmeier J; Lee K; Völker AK; Mahrhold S; Zong Y; Zeiser J; Zhou J; Pich A; Bigalke H; Binz T; Rummel A; Jin R
Biochem J; 2010 Oct; 431(2):207-16. PubMed ID: 20704566
[TBL] [Abstract][Full Text] [Related]
10. Mechanism of Ganglioside Receptor Recognition by Botulinum Neurotoxin Serotype E.
Masuyer G; Davies JR; Stenmark P
Int J Mol Sci; 2021 Aug; 22(15):. PubMed ID: 34361086
[TBL] [Abstract][Full Text] [Related]
11. Variations in the Botulinum Neurotoxin Binding Domain and the Potential for Novel Therapeutics.
Davies JR; Liu SM; Acharya KR
Toxins (Basel); 2018 Oct; 10(10):. PubMed ID: 30347838
[TBL] [Abstract][Full Text] [Related]
12. Crystal structure of the botulinum neurotoxin type G binding domain: insight into cell surface binding.
Stenmark P; Dong M; Dupuy J; Chapman ER; Stevens RC
J Mol Biol; 2010 Apr; 397(5):1287-97. PubMed ID: 20219474
[TBL] [Abstract][Full Text] [Related]
13. Crystal Structures of the
Gregory KS; Newell AR; Mojanaga OO; Liu SM; Acharya KR
Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36077016
[No Abstract] [Full Text] [Related]
14. A lipid-binding loop of botulinum neurotoxin serotypes B, DC and G is an essential feature to confer their exquisite potency.
Stern D; Weisemann J; Le Blanc A; von Berg L; Mahrhold S; Piesker J; Laue M; Luppa PB; Dorner MB; Dorner BG; Rummel A
PLoS Pathog; 2018 May; 14(5):e1007048. PubMed ID: 29718991
[TBL] [Abstract][Full Text] [Related]
15. Unique ganglioside recognition strategies for clostridial neurotoxins.
Benson MA; Fu Z; Kim JJ; Baldwin MR
J Biol Chem; 2011 Sep; 286(39):34015-22. PubMed ID: 21849494
[TBL] [Abstract][Full Text] [Related]
16. Structural and Biochemical Characterization of Botulinum Neurotoxin Subtype B2 Binding to Its Receptors.
Davies JR; Masuyer G; Stenmark P
Toxins (Basel); 2020 Sep; 12(9):. PubMed ID: 32957706
[TBL] [Abstract][Full Text] [Related]
17. Synaptotagmin Binding to Botulinum Neurotoxins.
Martínez-Carranza M; Blasco P; Gustafsson R; Dong M; Berntsson RP; Widmalm G; Stenmark P
Biochemistry; 2020 Feb; 59(4):491-498. PubMed ID: 31809018
[TBL] [Abstract][Full Text] [Related]
18. Exchange of the H(CC) domain mediating double receptor recognition improves the pharmacodynamic properties of botulinum neurotoxin.
Rummel A; Mahrhold S; Bigalke H; Binz T
FEBS J; 2011 Dec; 278(23):4506-15. PubMed ID: 21624052
[TBL] [Abstract][Full Text] [Related]
19. The biological activity of botulinum neurotoxin type C is dependent upon novel types of ganglioside binding sites.
Strotmeier J; Gu S; Jutzi S; Mahrhold S; Zhou J; Pich A; Eichner T; Bigalke H; Rummel A; Jin R; Binz T
Mol Microbiol; 2011 Jul; 81(1):143-56. PubMed ID: 21542861
[TBL] [Abstract][Full Text] [Related]
20. Structural analysis of the catalytic and binding sites of Clostridium botulinum neurotoxin B.
Swaminathan S; Eswaramoorthy S
Nat Struct Biol; 2000 Aug; 7(8):693-9. PubMed ID: 10932256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]